Birgit Girshick

Birgit Girshick is a declared insider of Charles River Laboratories International, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 1 March 2021 and 19 August 2026, the trades on record add up to 38 filings.

In open-market terms, that means 1 purchase worth €239k on one side and 2 sales worth €1.6M on the other. On balance, insiders were net sellers of €1.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 22 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

The newest entry dates from 20 August 2026: a transaction, in Charles River Laboratories International, Inc. The last purchase on record was published on 21 February 2025, which is 604 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.